A Resource for Healthcare and Social Services Professionals
The Medication Access and Training Expansion (MATE) Act was included in the Consolidated Appropriations Act. Effective June 27th, 2023, the U.S. Department of Justice Drug Enforcement Administration (DEA) requires all DEA-registered practitioners to complete a one-time, 8-hour training requirement on treating and managing patients with opioid or other substance use disorders.
*You are required to attest to fulfilling these requirements when registering with the DEA. We do not communicate your participation in trainings to the DEA.
ACCREDITATION for trainings offering CME, Nursing and Pharmacology credits:
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
For more DEA-related questions and information, including deadlines, registration requirements, training requirements, etc. please visit the DEA website.
For questions regarding Grayken TTA’s trainings and offerings, please email us at firstname.lastname@example.org.